Navigation Links
A 'grape' future for Alzheimer's disease research
Date:11/6/2007

With National Alzheimers Awareness Month upon us, attention continues to focus on new approaches to cognitive health in an aging population. Now, research with grape polyphenols presented today at Neuroscience 2007 in San Diego shows promise for maintaining long-term cognitive health. The researchers will now focus on grape polyphenols and Alzheimers disease (AD) at the newly established Center for Research in Alternative and Complementary Medicine in Alzheimers disease research at Mount Sinai School of Medicine (MSSM).

Two recent population studies associated moderate red wine and 100 percent fruit juice consumption with lowering the risk of AD dementia (wine) or delay in AD onset (juice). Adding further weight to those studies is the research presented by Dr. Lap Ho at Neuroscience 2007, which demonstrated the potentially protective effect of Concord grape juice and Cabernet Sauvignon polyphenols to slow beta-amyloid neuropathology.

A characteristic hallmark of Alzheimers disease-type neuropathology is the accumulation of beta-amyloid peptides and their formation into plaques in the brain. Dr. Ho at MSSM found that polyphenol extracts from Cabernet Sauvignon and Concord grape juice reduced the generation and accumulation of beta-amyloid peptides in experimental models of Alzheimers disease.

This grape polyphenol research is preliminary, but very encouraging, said Dr. Giulio Pasinetti, director of the new center and principal investigator of the research program in polyphenolics at MSSM. The results show the potential protective role which non-alcoholic, polyphenol-rich Concord grape juice may play in maintaining long term cognitive health.

Previous work by Dr. Pasinettis group at MSSM reported that moderate consumption of Cabernet Sauvignon wine had reduced AD-type neuropathology and prevented cognitive decline in a transgenic mouse model , yet counseled that even moderate intake of alcohol may carry health risks, particularly with an older population.

Currently, it is estimated that five million people in the United States suffer from Alzheimers disease, with the number projected to reach 11 to 16 million by the year 2050. However, delaying the onset of Alzheimers disease by five years is estimated to potentially reduce the number of projected cases by 50 percent. Ongoing studies directed by Dr. Pasinetti at the new center will provide critical information about the functional role of selected grape-derived polyphenols in the prevention and/or attenuation of cognitive deterioration of Alzheimers disease.

Our goal is to learn which compounds are bioactively available to reach the brain and exert a benefit, says Dr. Pasinetti.


'/>"/>

Contact: Amy Coles
acoles@hunterpr.com
212-679-6600
Hunter Public Relations
Source:Eurekalert

Related medicine news :

1. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
2. New All-Natural Dietary Supplement Made from Muscadine Grape Skins Helps Inhibit Growth of Certain Cancers
3. Red wine and grape juice help defend against food-borne diseases, according to MU researchers
4. Grape Consumption Improves Antioxidant Capacity in Humans
5. Researchers study potential health benefits of natural chemicals in muscadine grape seeds
6. Grapes in Diet Decrease Risk of Hypertensive Heart Failure
7. Campaign for Americas Future Memorandum: Katrina Storm Warning
8. Shipcom Partners With DOKUMENTA for METROs Future Store Initiative
9. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
10. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
11. The Humana Foundation and Libraries for the Future Launch Health Literacy Pilot in Atlanta
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women ... diagnosed with endometriosis. These women need a treatment plan to not only alleviate ... that can help for preservation of fertility and ultimately achieving a pregnancy. The ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: